Imricor Medical Systems, Inc. (ASX: IMR)

Imricor Medical Systems Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	250	96	55	144	284	111
Market Cap Growth	114.53%	74.29%	-61.62%	-49.27%	155.25%	-
Enterprise Value	262	103	45	126	271	128
Last Close Price	0.93	0.55	0.35	0.97	2.19	1.16
PS Ratio	131.93	106.62	46.01	150.33	311.76	122.08
PB Ratio	-11.15	-7.50	5.00	4.67	7.60	11.10
P/TBV Ratio	-	-	5.00	4.67	7.60	11.10
EV/Sales Ratio	211.88	114.13	37.28	131.63	298.01	140.59
Debt / Equity Ratio	-1.46	-1.22	0.59	0.08	0.09	0.28
Asset Turnover	0.10	0.06	0.04	0.02	0.03	0.08
Inventory Turnover	0.85	0.87	0.96	0.92	0.51	0.47
Quick Ratio	0.64	0.27	2.80	6.80	11.03	3.72
Current Ratio	1.46	0.86	4.67	8.30	12.58	4.78
Return on Equity (ROE)	-	-	-116.05%	-77.06%	-69.44%	-2333.49%
Return on Assets (ROA)	-124.67%	-95.73%	-53.19%	-41.90%	-33.90%	-51.96%
Return on Capital (ROIC)	-242.30%	-151.39%	-59.77%	-45.67%	-37.07%	-64.39%
Earnings Yield	-28.25%	-34.47%	-46.23%	-18.85%	-5.69%	-17.02%
FCF Yield	-20.68%	-19.90%	-44.61%	-17.31%	-5.93%	-8.95%
Buyback Yield / Dilution	-17.63%	-7.46%	-11.42%	-18.76%	-81.97%	-44.12%
Total Shareholder Return	-17.63%	-7.46%	-11.42%	-18.76%	-81.97%	-44.12%

Source: S&P Capital IQ. Standard template. Financial Sources.